skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 44  for All Library Resources

Results 1 2 3 next page
Show only
Refined by: New Records: New From Last Month remove subject: Cost-Benefit Analysis remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Health-economic aspects of radiotherapy
Material Type:
Article
Add to My Research

Health-economic aspects of radiotherapy

Revue médicale de Liège, 2024-05, Vol.79 (S1), p.117-122 [Peer Reviewed Journal]

ISSN: 0370-629X ;PMID: 38778659

Full text available

2
Feed-in-tariff is key to Japan’s current biomass power’s viability, even with environmental externalities
Material Type:
Article
Add to My Research

Feed-in-tariff is key to Japan’s current biomass power’s viability, even with environmental externalities

Environmental Research Communications, 2024-05, Vol.6 (5), p.055018 [Peer Reviewed Journal]

2024 The Author(s). Published by IOP Publishing Ltd. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2515-7620 ;DOI: 10.1088/2515-7620/ad4a28

Full text available

3
Cost-effectiveness of drug consumption rooms in France: a modelling study
Material Type:
Article
Add to My Research

Cost-effectiveness of drug consumption rooms in France: a modelling study

BMC public health, 2024-05, Vol.24 (1), p.1426-1426 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;The Author(s) 2024 ;ISSN: 1471-2458 ;EISSN: 1471-2458 ;DOI: 10.1186/s12889-024-18909-9 ;PMID: 38807111

Full text available

4
Cost-effectiveness analysis of tislelizumab vs. camrelizumab for the treatment of second-line locally advanced or metastatic esophageal squamous cell carcinoma
Material Type:
Article
Add to My Research

Cost-effectiveness analysis of tislelizumab vs. camrelizumab for the treatment of second-line locally advanced or metastatic esophageal squamous cell carcinoma

BMC health services research, 2024-05, Vol.24 (1), p.676-676 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;The Author(s) 2024 ;ISSN: 1472-6963 ;EISSN: 1472-6963 ;DOI: 10.1186/s12913-024-11142-5 ;PMID: 38807104

Full text available

5
Immune checkpoint inhibitors as the second-line treatment for advanced esophageal squamous cell carcinoma: a cost-effectiveness analysis based on network meta-analysis
Material Type:
Article
Add to My Research

Immune checkpoint inhibitors as the second-line treatment for advanced esophageal squamous cell carcinoma: a cost-effectiveness analysis based on network meta-analysis

BMC cancer, 2024-05, Vol.24 (1), p.654-654 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;The Author(s) 2024 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12423-2 ;PMID: 38811891

Full text available

6
A cost-benefit analysis of WildFireSat, a wildfire monitoring satellite mission for Canada
Material Type:
Article
Add to My Research

A cost-benefit analysis of WildFireSat, a wildfire monitoring satellite mission for Canada

PloS one, 2024-05, Vol.19 (5), p.e0302699-e0302699 [Peer Reviewed Journal]

Copyright: © 2024 Hope et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ;COPYRIGHT 2024 Public Library of Science ;2024 Hope et al 2024 Hope et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0302699 ;PMID: 38781185

Full text available

7
Economic evaluation of trastuzumab in HER2-positive early breast cancer in Indonesia: A cost-effectiveness analysis
Material Type:
Article
Add to My Research

Economic evaluation of trastuzumab in HER2-positive early breast cancer in Indonesia: A cost-effectiveness analysis

PloS one, 2024-05, Vol.19 (5), p.e0304483-e0304483 [Peer Reviewed Journal]

Copyright: © 2024 Khoirunnisa et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ;COPYRIGHT 2024 Public Library of Science ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0304483 ;PMID: 38787899

Full text available

8
Cost-effectiveness analysis of surgical masks, N95 masks compared to wearing no mask for the prevention of COVID-19 among health care workers: Evidence from the public health care setting in India
Material Type:
Article
Add to My Research

Cost-effectiveness analysis of surgical masks, N95 masks compared to wearing no mask for the prevention of COVID-19 among health care workers: Evidence from the public health care setting in India

PloS one, 2024-05, Vol.19 (5), p.e0299309-e0299309 [Peer Reviewed Journal]

Copyright: © 2024 Sharma et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ;COPYRIGHT 2024 Public Library of Science ;2024 Sharma et al 2024 Sharma et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0299309 ;PMID: 38768249

Full text available

9
Cost-effectiveness of strength exercise or aerobic exercise compared with usual care for patients with knee osteoarthritis: secondary results from a multiarm randomised controlled trial in Norway
Material Type:
Article
Add to My Research

Cost-effectiveness of strength exercise or aerobic exercise compared with usual care for patients with knee osteoarthritis: secondary results from a multiarm randomised controlled trial in Norway

BMJ open, 2024-05, Vol.14 (5), p.e079704-e079704 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2023-079704 ;PMID: 38803266

Full text available

10
Protocol for cost-effectiveness analysis of a randomised trial of mHealth coaching (Bump2Baby and Me) compared with usual care for healthy gestational weight gain and postnatal outcomes in at-risk women and their offspring in the UK, Australia, Ireland and Spain
Material Type:
Article
Add to My Research

Protocol for cost-effectiveness analysis of a randomised trial of mHealth coaching (Bump2Baby and Me) compared with usual care for healthy gestational weight gain and postnatal outcomes in at-risk women and their offspring in the UK, Australia, Ireland and Spain

BMJ open, 2024-05, Vol.14 (5), p.e080823-e080823 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2024 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2023-080823 ;PMID: 38772891

Full text available

11
Comparing the effectiveness and cost-effectiveness of sulfonylureas and newer diabetes drugs as second-line therapy for patients with type 2 diabetes
Material Type:
Article
Add to My Research

Comparing the effectiveness and cost-effectiveness of sulfonylureas and newer diabetes drugs as second-line therapy for patients with type 2 diabetes

BMJ open diabetes research & care, 2024-05, Vol.12 (3), p.e003991 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2024 ;EISSN: 2052-4897 ;DOI: 10.1136/bmjdrc-2023-003991 ;PMID: 38802266

Full text available

12
Reducing overdose deaths among persons with opioid use disorder in connecticut
Material Type:
Article
Add to My Research

Reducing overdose deaths among persons with opioid use disorder in connecticut

Harm reduction journal, 2024-05, Vol.21 (1), p.103-103 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;The Author(s) 2024 ;ISSN: 1477-7517 ;EISSN: 1477-7517 ;DOI: 10.1186/s12954-024-01026-6 ;PMID: 38807226

Full text available

13
Cost‐Effectiveness and Budget Impact Analysis of the Implementation of Differentiated Service Delivery Models for HIV Treatment in Mozambique: a Modelling Study
Material Type:
Article
Add to My Research

Cost‐Effectiveness and Budget Impact Analysis of the Implementation of Differentiated Service Delivery Models for HIV Treatment in Mozambique: a Modelling Study

Journal of the International AIDS Society, 2024-05, Vol.27 (5), p.e26275-n/a [Peer Reviewed Journal]

2024 The Author(s). published by John Wiley & Sons Ltd on behalf of International AIDS Society. ;2024 The Author(s). Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of International AIDS Society. ;2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1758-2652 ;EISSN: 1758-2652 ;DOI: 10.1002/jia2.26275 ;PMID: 38801731

Full text available

14
Fuzzy Few-Shot Learning for Predictive Maintenance and Cost-Benefit Analysis in Semiconductor Manufacturing: A Case Study on Photomask Haze
Material Type:
Article
Add to My Research

Fuzzy Few-Shot Learning for Predictive Maintenance and Cost-Benefit Analysis in Semiconductor Manufacturing: A Case Study on Photomask Haze

IEEE access, 2024-01, Vol.12, p.1-1 [Peer Reviewed Journal]

Copyright The Institute of Electrical and Electronics Engineers, Inc. (IEEE) 2024 ;EISSN: 2169-3536 ;DOI: 10.1109/ACCESS.2024.3405540 ;CODEN: IAECCG

Full text available

15
Fair Funding Decisions: Consistency of the Time Horizons Used in the Calculation of Quality-Adjusted Life Years for Therapies for Very Rare Diseases by the National Institute for Health and Care Excellence in England
Material Type:
Article
Add to My Research

Fair Funding Decisions: Consistency of the Time Horizons Used in the Calculation of Quality-Adjusted Life Years for Therapies for Very Rare Diseases by the National Institute for Health and Care Excellence in England

International journal of environmental research and public health, 2024-05, Vol.21 (5), p.616 [Peer Reviewed Journal]

2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1661-7827 ;EISSN: 1660-4601 ;DOI: 10.3390/ijerph21050616 ;PMID: 38791830

Full text available

16
Clinical and cost-effectiveness of pessary self-management versus clinic-based care for pelvic organ prolapse in women: the TOPSY RCT with process evaluation
Material Type:
Article
Add to My Research

Clinical and cost-effectiveness of pessary self-management versus clinic-based care for pelvic organ prolapse in women: the TOPSY RCT with process evaluation

Health technology assessment (Winchester, England), 2024-05, Vol.28 (23), p.1-121 [Peer Reviewed Journal]

ISSN: 1366-5278 ;EISSN: 2046-4924 ;DOI: 10.3310/NWTB5403 ;PMID: 38767959

Full text available

17
Modeling the economic value of cardiometabolic virtual-first care programs
Material Type:
Article
Add to My Research

Modeling the economic value of cardiometabolic virtual-first care programs

The American journal of managed care, 2024-05, Vol.30 (6 Spec No.), p.SP430-SP436 [Peer Reviewed Journal]

Copyright MultiMedia Healthcare Inc. 2024 ;ISSN: 1088-0224 ;EISSN: 1936-2692 ;DOI: 10.37765/ajmc.2024.89549 ;PMID: 38820183

Full text available

18
Cost-effectiveness of ivosidenib versus chemotherapy for previously treated IDH1-mutant advanced intrahepatic cholangiocarcinoma in Taiwan
Material Type:
Article
Add to My Research

Cost-effectiveness of ivosidenib versus chemotherapy for previously treated IDH1-mutant advanced intrahepatic cholangiocarcinoma in Taiwan

BMC cancer, 2024-05, Vol.24 (1), p.622-622 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;The Author(s) 2024 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12362-y ;PMID: 38778261

Full text available

19
High-precision stereotactic irradiation for focal drug-resistant epilepsy versus standard treatment: a randomized waitlist-controlled trial (the PRECISION trial)
Material Type:
Article
Add to My Research

High-precision stereotactic irradiation for focal drug-resistant epilepsy versus standard treatment: a randomized waitlist-controlled trial (the PRECISION trial)

Current controlled trials in cardiovascular medicine, 2024-05, Vol.25 (1), p.334-334 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;ISSN: 1745-6215 ;EISSN: 1745-6215 ;EISSN: 1468-6694 ;DOI: 10.1186/s13063-024-08168-9 ;PMID: 38773643

Full text available

20
Mitigating ammonia and greenhouse gas emissions from stored cattle slurry using agricultural waste, commercially available products and a chemical acidifier
Material Type:
Article
Add to My Research

Mitigating ammonia and greenhouse gas emissions from stored cattle slurry using agricultural waste, commercially available products and a chemical acidifier

Journal Of Cleaner Production, 2021-02 [Peer Reviewed Journal]

Attribution-NonCommercial-NoDerivs 3.0 Ireland https://creativecommons.org/licenses/by-nc-nd/3.0/ie ;ISSN: 0959-6526 ;EISSN: 1879-1786 ;DOI: 10.1016/j.jclepro.2021.126251

Digital Resources/Online E-Resources

Results 1 - 20 of 44  for All Library Resources

Results 1 2 3 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (36)

Refine My Results

Creation Date 

From To
  1. Before 2006  (1)
  2. 2006 To 2020  (1)
  3. 2021 To 2021  (1)
  4. 2022 To 2023  (3)
  5. After 2023  (39)
  6. More options open sub menu

Language 

  1. English  (41)
  2. French  (1)
  3. Swedish  (1)
  4. Czech  (1)
  5. More options open sub menu

Searching Remote Databases, Please Wait